chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No adverse events were reported; Products were administered post TE; This spontaneous report was received from a registered nurse referring to a 33-year-old patient of unknown gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided.     On 20-APR-2023, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) injection (lot # W008711, expiration date: 14-MAR-2024 or lot # W017552, expiration date: 01-JUN-2024; no exact lot# and expiration date was provided) (both strengths, doses, routes of administration and anatomical locations were not reported), both for prophylaxis (product storage error). No additional adverse event (AE) was reported (no adverse event).  This case was received from the same reporter with another 17 cases: 2305USA007704, 2305USA009079,2305USA009080,2305USA009081,2305USA009082, 2305USA009083, 2305USA009084, 2305USA009085, 2305USA009086, 2305USA009087, 2305USA009088, 2305USA009089, 2305USA009090, 2305USA009091, 2305USA009093, 2305USA009094, 2305USA009095.
I received 2 Pfizer COVID-19 vaccines - 4/10/2021 and 5/1/2021 at the Fairgrounds.  I have tried to report this information to the CDC VAERS online and keep getting bounced. As I had been asked to present at a conference in in October I wanted to make sure I had antibodies. My PCP ordered the SARS CoV 2AB (igG) Nucleo Capside QI lab test on August 4, 2021. No detectable antibodies were found (titer < 1.0).  As I have no underlying immune-compromised conditions there is no plausible medical reason for the lack of an antibody response.  Therefore, I thought this should be reported.  Perhaps there is a problem with the refrigeration or other handling of the lots involved with my vaccination.
Weakness Dizzy Lethargic No Appetite Bed Ridden Long Period of Headaches Hot Flashes.
Felt dizzy, "numb cheeks" within 5 minutes after receiving vaccine.  Vitals were stable.  Medics called to evaluate.  Not transported to the hospital.  Felt better and friend drove her home.
I developed alopecia areata after receiving this vaccine.  This condition begins around 60 days following an event.  (January) I began to notice hair loss in March of 2021.  My hair has continued to fall out to this day and will probably continue to fall out until around August.  I am hoping not to have total hair loss but I have already purchased wigs and have costs for PCP follow up, Dermatology visit and injections and immunologist visit.
HA, SORE THROAT, DRY COUGH, FATIGUE, MILD MYALGIAS. TX WITH TAMIFLU 9/7/14.
The patient received an improperly stored dose of PROQUAD.; No adverse effects reported.; This spontaneous report was received from the Vaccine Coordinator referring to a patient of unknownn age and gender. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported.   On 15-OCT-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live  recombinant Human albumin ( rHA) (PROQUAD) with lot # S008578 and expiration date on 16-SEP-2020 (Strength, route, dose, frequency, and anatomical location were unknown) for prophylaxis.   The administered dose of vaccine experienced the temperature excursion of 6°F to 14°F degrees Fahrenheit for 2 hours and 35 minutes and 15°F to 46°F (16.3°F) for 44 minutes. There was a digital data logger involved, but there was no previous temperature excursion.
This non-valid spontaneous report was received from a nurse and refers to unspecified patients of unknown age and gender. On an unknown date, the patients were vaccinated with incorrectly storage GARDASIL 9 (dose, route of administration, lot # and expiration date were unspecified), M-M-R II (dose, route of administration, lot # and expiration date were unspecified) and ROTATEQ orally (dose, lot # and expiration date were unspecified) all for prophylaxis. No adverse event were reported. Digital data logger was involved.
Received Pneumonia vaccine on Thursday. 9am, by 2pm couldn't lift arm without quite a bit of pain. Thursday night barely slept body pain throughout. Sleep 60 min, up 90 min thru entire night. Extreme nausea and fever started by 4am. Fully medicated with both acetaminophen and ibuprofen piggyback I still ran a 102.6 fever majority of Friday. Thought of going to ER, heart palpitations too. Increase in pain in arm. Up and down thru Friday night. Vomiting. Sat only low grade to no fever. Arm is now beyond painful. Even my shirt touching is torture, it is hot, red, swollen. Pain radiating all the way to fingertips. Had to draw a line on arm of redness outer boundary to see if it'd increase in size. Still nauseous almost all day had some dinner and living on freezer pops to keep food down. Took a benedryl before bed in case it's any allergic reaction. Headache and migraines throughout. Praying since they placed the shot so high it's not into bursa sack. I have rheumatoid arthritis and had shoulder bursitis In past. If they know giving too high is a problem then why on Earth do they? Woke up Sunday morning after another fitful pained night. Fever seems to be gone, stomach feeling a bit better, arm same if not worse. No spread of red swollen area, extreme pain and radiating down into elbow and fingers. The list of side effects is missing a lot of information especially as far as the extreme of all of it and fever that nearly out me in hospital. No end of relief of pain in site, day 4.
Moderna COVID-19 Vaccine EUA.   No issues during shot itself.  Had sore arm (no redness) and what felt like a lump at injection site for approx. 4 days.  Started to itch on 5th day, next day had red lump aprox 1 inch across at  injection site.  Still sore to touch. Did not treat with anything, but did rub area with hand. Today the 1 inch red area is still there, but now a less red approx 2 inches edge all around the darker red area....so total area affected is approx. 3-4 inches across.  No other problems.  (Checked CDC site...I believe its the typical "covid arm".
Developed area approx 8" x 4" (R) valar aspect (R) upper arm - marked leg red, swollen and painful on day 7-17-13 evening, very painful. Did have chills and fever too last night. Will take BENADRYL and apply ice to area. Infection site clear.
Marked swelling of left thigh compared to right with patchy erythema, and warmth.  Fevers starting the day after vaccination to 102, and up to 105 F on 9/3. Concern for cellulitis vs. localized reaction to vaccine.  Started on treatment with empiric clindamycin.
This case was reported by a consumer via out of hour services and described the occurrence of shingles in a female patient who received Shingles vaccine. In January 2018, the patient received shingles vaccine. In January 2018, less than a month after receiving Shingles vaccine, the patient experienced skin ulcer. On 4th February 2018, the patient experienced shingles, frustration and rash. The patient was treated with acyclovir. On an unknown date, the outcome of the shingles, frustration, skin ulcer and rash were unknown. It was unknown if the reporter considered the shingles, frustration, skin ulcer and rash to be related to Shingles vaccine. Additional details were provided as follows: The age at vaccination was not reported. The patient did not recall the vaccine name. The patient clarified that she received shingles shot three weeks ago from the date of reporting, and started experiencing shingles rash. Less than a month after receiving Shingles vaccine, the patient was absolutely broken out in shingles and her whole face was a one huge rash from one side and it was actually starting to travel over my nose to the other side of her face. It was in her eye. Less than a month after receiving Shingles vaccine, the patient was really frustrated. The patient reported that she did not have shingles and she thought because she was getting older, and she would have a shingles shot. Less than a month after receiving Shingles vaccine, this was became absolutely horrific and horrible. The patient went to the doctors and they had given her a medication but the medication was not working so it was continuously spreading. The patient was prescribed with acyclovir tablets as a treatment medication. Less than a month after receiving Shingles vaccine, the patient was broken out in sores like 6 days ago from the date of reporting. The patient asked, it would be great if somebody could called her back and might gave her something else or advise her something else to do. The patient denied the permission for follow up.
Patient mother reports patient experienced hives at site of injection on the day of injection, patient reported to local urgent care on 10/21/2018 where was seen and was told to take BENADRYL and was given an Rx for a short course of prednisone 20mg oral two times a day for 5 days; counseled patient mother to follow up if reaction gets worse; patient mother states patient not experiencing much discomfort after BENADRYL.
flu shot administeRed 11/2. On 11/3 woke up with welts on legs + Ribs. Pt called doctoR - told to take benadRyl. A few days lateR when not healed md advised the pt to add ClaRitin. Pt was seen on 11/10 and given hydRxyzine + medRol dose pack. They have also scheduled an appointment on 11/11 to see an allergist.
many patients with a rash from Moderna; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH (many patients with a rash from Moderna) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (many patients with a rash from Moderna). At the time of the report, RASH (many patients with a rash from Moderna) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medications are provided. treatment to the events not reported.
No adverse event; HCP reported following excursion 65.2F for 9 Hours 45 Minutes; 32.4F for 42 Hours 45 Minutes; This spontaneous report was received from a health care professional (HCP) and refers to a 7-week-old patient. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant therapies were not reported.  On 01-MAY-2023, the patient was vaccinated with inappropriate storage rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, lot #W020326, (expiration date: 17-OCT-2023), administered orally; and  diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS) injection (anatomical site injection and route of administration were not provided), lot #U7217AA, (expiration date: 12-NOV-2024), both vaccines administered for prophylaxis (strengths, doses were not provided) (product storage error) The HCP reported following temperature excursion 65.2 Fahrenheit for 9 hours 45 minutes; and 32.4F Fahrenheit for 42 hours 45 minutes for both vaccines. No adverse event was reported.  This is one of several reports  from the same reporter.
I started having chills, light fever, and muscle discomfort starting about 10 hours following my vaccination. For the next 24 hours after that, I experienced chills, muscle discomfort, and injection site discomfort.
<5 min O/P IM injection, induration and erythema spread to 5.5cm x 4cm with central hematoma of 1.5 x 1cm2 (despite cool compress).
This is a spontaneous report received from a noncontactable consumer or other non-HCP (patient), for a Pfizer sponsored program (159558). A female patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient developed nasopharyngitis (a cold) and nasal congestion (stuffy nose), with outcome of not recovered. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
This spontaneous report received from a registered nurse refers to a 4 year old female patient. The patient's illness and medical conditions at time of vaccination included epilepsy, developmental delay, failure to thrive (FTT) and insomnia. Historical vaccines were not reported. On 20-SEP-2018, the patient was vaccinated with M-M-R II dose 2, subcutaneous in the left thigh and with QUADRACEL. Both vaccines were administered for prophylaxis and purchased with public funds. Other suspect therapies included levetiracetam (KEPPRA) 1.4 ml total dose orally for epilepsy, and clonidine 0.1 mg total dose orally for insomnia. The administered doses of the vaccines experienced a freezer temperature excursion (not specified) (product storage error) as recorded from a digital data logger which ocurred at the time of storage in clinical practice. No adverse effect was reported. Lot number R011802 is an invalid lot number for M-M-R II. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1901USA002753: US-009507513-1901USA002754: US-009507513-1901USA002755: US-009507513-1901USA002756: US-009507513-1901USA002757: US-009507513-1901USA002758: US-009507513-1901USA002759: US-009507513-1901USA002760: US-009507513-1901USA002761: US-009507513-1901USA002762: US-009507513-1901USA002763: US-009507513-1901USA002764: US-009507513-1809USA010598:
Fever/chills, headache, cold over kidneys, pain torso and head, fever wo chills, chills wo fever.  Very strong and relentless sx for 12 hours. Injection site swelling/inflam/heat larger than flat hand with fingers close together.
Headache , joint pain, body aches, fever 100.4, soreness and redness at the injection site  24-48 hours
chills; hot flashes; developed difficulty breathing; chest discomfort; body aches; Joint pain; 100.1F; This is a spontaneous report from a contactable consumer (patient). A female patient of 56 (units not provided) age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: Unknown), via an unspecified route of administration on 28Feb2021 as single dose for COVID-19 immunisation. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection) on 09Feb2021 for COVID-19 immunisation and had no symptoms. Medical history included ongoing asthma. The patient's concomitant medications were not reported. She received second dose on 28Feb2021 and that evening at 11pm developed difficulty breathing, chills for a few hours, hot flashes and chills. Then at 5am, she developed body aches, joint pain, 100.1F. Last night, she felt better. This morning she having chest discomfort, no pain, no difficulty breathing. She used her inhaler and it "calmed down" a little bit. She wants to know this is common side effect or should she see doctor. The patient underwent lab tests and procedures which included body temperature: 100.1F. The patient received treatments due to difficulty breathing with inhaler. The outcome of developed difficulty breathing and chest discomfort was unknown, while with other events was recovered on an unspecified date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
client reported tingling sensation down the left arm 15 minutes after vaccination; seen & cleared by EMS. B/P- 125/75, P- 87
Child received DTaP, IPV, and MMRV on 8/6/07.  Mother called 8/13/07 to state that she noticed a rash when the child woke up that morning.  The rash was over the body. On 8/14/07 the mother called back to state that the rash had progressed and that the child's eyes were nearly swollen shut.  Mother was asked to take the child to the doctor.  Mother called to report that the doctor did not believe the rash was from the vaccines and that the child's rhumatologist thought that it was hives.  The mother is taking the child to doctor's office on 8/17/07.
Approximately 72 hrs after administration developed axillary lymphadenopathy; This is a spontaneous report from a contactable consumer (patient himself). A 61-year-old male patient received his second dose of bnt162b2 (BNT162B2 also reported as COVID 19 vaccine brand Pfizer, lot/batch number and expiry date were not reported), via an unspecified route of administrationin the left leg on 14Jan2021 16:00 at SINGLE DOSE for Covid-19 immunisation. He received the vaccine in a hospital. Medical history included multiple seasonal environmental allergies. He received his first dose of bnt162b2 on 24Dec2020 12:00 in the left arm. Concomitant medications included fexofenadine hydrochloride (ALLEGRA), ibuprofen (ADVIL), aluminium hydroxide gel, dried, magnesium carbonate (PEPCID) and acetylsalicylic acid (BABY ASPIRIN). Approximately 72hrs after administration (17Jan2021 23:00), he developed an axillary lymphadenopathy (non-serious). Since the vaccination, he had not been tested for COVID-19. No treatment given. The outcome of event was not recovered.    Information on the lot number has been requested.
pt recv vax; 19jul rash & itching; 21jul to MD w/ rash mostly on face, itching; depomedrol given & ordered diphenigram;dx w/ allergic rxn to vax; rash still there
Patient received her first dose of the Pfizer COVID19 vaccine at approximately 12pm. Patient felt fine immediately after the vaccination and was instructed to sit and wait for 15 minutes. The immunizer, watched the patient sit down in a chair. A few minutes later the mother of that patient began screaming help, help. Patient had fainted, falling on the floor and hitting her head. I ran our to assist patient, I instructed my technicians to call 911. Patient was on the floor, shaking. I assisted her in rolling over. When she came to I helped her control her breathing and take deep breaths. I used I gauze pad to stop the bleeding on her head. I made sure she was lying flat on the floor. We gave her an ice pack to help with the numbness and tingling in her hands. The paramedics arrived and took patient to the hospital.
Arm was very store couldn't lift then went to physician on 11/14/16 and was given Ibuprofen 800. She also followed up with her regular physician. He is seeing her for physical therapy.
Information has been received regarding a case in litigation concerning a patient (age and gender unknown) who was vaccinated (route unknown) with 3 doses of PedvaxHIB (lot#627932/0981H, 626622/0427H, and 626413/0215H). Subsequently, on an unknown date the patient experienced an unspecified adverse experience. The outcome of the patient's experience was not reported. No further information is available.
10 days after receiving 2nd dose extreme body aches, sight headache and fatigue. 7/2/2021 labs drawn for autoimmune testing all negative sed. Rate normal.  Pain continued ankles, feet, wrist, hands , and hip/girdle pain and very stiff and weak feeling but muscle tone was strong. PCP visit 16th. He thought i had Polymyalgia rheumatica. Prescribed 20mg of prednisone daily. Then gradual taper. Some lingering discomfort
Left deltoid area redness, itching within 4-5 hrs about 4x8cm.
Vaccine given 4/7/21 and 4/29/21. On 5/4  Started having symptoms of Shingles.  On 5/12/21 we went to an urgent care clinic. They diagnosed her as having Shingles.
Genital itching/irritation started 10/9.  Treated with Benzocaine 5%/Resorcinol 2% topical ointment for 12 days.  Subsequently developed sore throat and congestion starting 10/13.  Developed fungal rash under breasts and band of itching/hives on scalp, ears and neck beginning 10/14.  Seen by physician 10/15 and started on course of steroids (oral) and fungicide topical ointment.  Responding to treatment (rash almost resolved) as of 10/21/14.
c/o stinging when it went in redness x 3" @ site of inject; ice pack applied; no induration, mild tenderness; DPH given;
Patient presents to the ED on 01/15/2022  with a Chief Complaint of Back Pain and Abdominal Pain after receiving the covid-19 vaccine on 01/06/2022. Per guidelines, all hospitalizations are reported.
Hardness at injection site; Redness at injection site; A spontaneous report was received from a female consumer (age not provided) who developed hardness/Induration and redness/Erythema at the injection site.  The patient's medical history was not provided. Concomitant product use was not provided.  On 03-Jan-2021, prior to the onset of events, the patient received the first of two planned doses of mRNA-1273 (Batch number not provided) (injection site not provided) for prophylaxis of Covid-19 infection.  On 11-Jan-2021, the patient developed a hardness and some redness at the injection site. On 12-Jan-2021, the redness is larger and the hardness was gone. The patient denied any pain. Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was unknown.  The event, Hardness outcome was considered resolved. The event Redness outcome was considered unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
patient received an improperly stored vaccine; This spontaneous report was received from a Registered Nurse and refers to a patient of unknown age and gender. Information regarding the patient's concomitant therapies, concurrent conditions, medical history and historical drugs was not provided.  On an unknown date, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) Subcutaneous Injection lot # T009929, expiration date 16-SEP-2021,  1 dosage form for prophylaxis (patient route of administration was not provided).  The improperly stored dose of the suspect vaccine experienced a temperature excursion of -6.6 degree Celsius (°C) for 1 hour and 45 minutes on 20-OCT-2020; no previous temperature excursion were reported.  The call was made due to a digital data logger. No adverse symptoms were reported.  This is one of several cases from the same reporter.; Sender's Comments:  US-009507513-2010USA010299: US-009507513-2010USA010508: US-009507513-2010USA010577: US-009507513-2010USA010709: US-009507513-2010USA010735:
3/26 - left arm at injection site became swollen, itchy, red and warm to the touch, right side of face in the upper lip and gum area experiencing numbness affect .
pt noted area of redness, warmth & tenderness about size of fifty cents piece around inj site 24hr p/vax;no resp distress, rash or other sx;
within 24 hours of vaccine high fever of 103, headache, very fatigue, chills; red left eye (infection) a few days later.
Within 7 hours I started to have menstral spotting and severe cramping.  Bleeding became heavier 24 hours after shot as did cramping and headache.  Bleeding and cramping was heavy for 9 days. Today day 10 I am just spotting lightly.   My normal period would not be until around the 28th of April.  This was two weeks earlier and I am always regular. And the length of time and cramping was also not normal for me during a regular period.
This spontaneous report as received from a 76 year old female subject which reported that a patient of unspecified age and gender was vaccinated with ZOSTAVAX (dose, therapy route and indication not reported) (Lot # not reported) on an unspecified date. On an unspecified date, the patient experienced blisters that appeared at her waist, the doctor confirmed shingles. On an unspecified date, the patient had experienced allergic reaction to medication and redness all over the body. This is a case of two from the same reporter. Additional information has been requested.
5 days after receiving the 2nd dose of COVID-19 vaccine, on March 2, 2021, she noticed hives over her body (on legs, arms and torso) that resolved by March 8, 2021.